Key result
Novel PRKAR1A splice mutation causes isolated PPNAD, resolving with bilateral adrenalectomy.
Case Report (n=1)
This case report identifies a novel germline PRKAR1A splice site mutation (c.709-5T>G) that causes exon 8 skipping and manifests as isolated PPNAD and secondary hypertension with incomplete familial penetrance.
Answers are grounded in this paper and cite their sources.
May support PRKAR1A testing in isolated PPNAD; hypothesis-generating for penetrance and variant spectrum.
Primary pigmented nodular adrenocortical disease (PPNAD) is a rare cause of Cushing syndrome, especially the isolated form without Carney complex, associated with germline mutations in PRKAR1A, the protein kinase A regulatory subunit type 1 alpha gene. We report a 31-year-old female who presented with secondary amenorrhea, cushingoid appearance, and hypertension without Carney complex. Biochemical laboratory examinations confirmed the ACTH-independent adrenal Cushing syndrome with negative Liddle test. A small right adrenal adenoma of 0.8 cm was shown on computed tomography while magnetic resonance imaging revealed nodularity of both adrenal glands. The histological report confirmed PPNAD using laparoscopic right adrenalectomy, and subsequent left adrenalectomy was performed 6 months later. She had inherited heterozygosity of a novel germline mutation of the PRKAR1A gene (g.114213T>G or c.709-5T>G). This splice site mutation results in exon 8 skipping. Her father carrying the same mutation had no clinical features of either PPNAD or Carney complex. This novel PRKAR1A gene mutation, c.709-5T>G, is reported here for the first time manifesting as an incomplete clinical expression of the isolated form of PPNAD and being inherited with low penetrance unlike other inherited mutations of the Carney complex which have a penetrance of almost 100%.
No takes yet. Share an insight, caveat, or question.
Korpaisarn et al. (2017) conducted a case report in Isolated primary pigmented nodular adrenocortical disease (iPPNAD) and ACTH-independent Cushing syndrome (n=1). Novel germline PRKAR1A gene mutation (g.114213T>G or c.709-5T>G) and staged bilateral laparoscopic adrenalectomy was evaluated on Genetic characterization and clinical remission of Cushing syndrome. A novel germline PRKAR1A splice site mutation (c.709-5T>G) resulted in exon 8 skipping and isolated PPNAD with incomplete penetrance, requiring bilateral adrenalectomy for Cushing syndrome resolution.
Synapse has enriched 10 related papers. Consider them for comparative context: